Company profile
DB · companies + sec_company_profileModerna, Inc. (MRNA) — the SEC company profile (description, website, HQ) has not been loaded for this ticker yet. Run the SEC profile loader to populate it.
AI description
Arphra AILoading cached description…
Identifiers
- SymbolMRNA
- Legal nameModerna, Inc.
- SectorHealthcare
- IndustryBiotechnology
- CountryUS
- CurrencyUSD
- ExchangeNASDAQ
- CIK0001682852
- ISIN—
- CUSIP—
- LEI—
- Employees—
Trading
DB · key_metrics_ttmMay 02, 2026- Market cap$17.99B
- P/E (TTM)—
- P/B—
- EV / EBITDA—
- Dividend yield—
Identifiers
OpenFIGI · GLEIFCross-source keys used to bridge FMP, SEC, and non-US data.
- FIGIBBG003PHHZT1
- CountryUS
Key executives
DB · executives| Name | Title | Compensation | Born | Since |
|---|---|---|---|---|
| Stéphane Bancel | Chief Executive Officer & Director | $6.14M | 1973 | — |
| Stephen Hoge | President | $4.26M | 1976 | — |
| Shannon Thyme Klinger | Chief Legal Officer & Corporate Secretary | $2.18M | 1971 | — |
| James Mock | Chief Financial Officer | $2.18M | 1977 | — |
| John Lepore | Senior Vice President of Government Engagement | — | — | — |
| Lavina Talukdar | Senior Vice President & Head of Investor Relations | — | 1975 | — |
| Melanie Ivarsson | Chief Development Officer | — | — | — |
| Patrick Norman Bergstedt | Senior Vice President of Commercial Vaccines | — | 1962 | — |